Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Spermatogenesis associated 13 (SPATA13) is a protein-coding gene encoding a guanine nucleotide exchange factor (GEF) that activates small GTPases such as Rac1, RhoA, and Cdc42, orchestrating actin cytoskeletal rearrangements essential for cell migration and adhesion[1][2][4][5]. SPATA13 interacts with proteins like the tumor suppressor APC and modulates membrane dynamics, lamellipodia, and filopodia formation[1]. Its activity is regulated by post-translational modifications—phosphorylation at serine 106 notably alters its ability to activate Rac1 and affect cell movement[1]. SPATA13 is implicated in human disease, notably primary angle-closure glaucoma, cancer progression, and rare neuropsychiatric disorders[1][2][3][5]. Its expression is enriched in brain regions such as the central amygdala, where loss of SPATA13 affects social behaviors and voluntary activity in animal models[3].
Not applicable/none reported. As of now, no drugs are noted to target SPATA13 directly, so mechanism by which drugs modulate its activity is undefined
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Spermatogenesis associated 13 (SPATA13).